A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Clinical trial NCT05907980 · RECRUITING
Trial details
- NCT number
- NCT05907980
- Sponsor
- Chugai Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2027-10-31
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.